Ischemia reperfusion-induced metastasis is resistant to PPARγ agonist pioglitazone in a murine model of colon cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Ischemia reperfusion-induced metastasis is resistant to PPARγ agonist pioglitazone in a murine model of colon cancer ; volume:10 ; number:1 ; day:29 ; month:10 ; year:2020 ; pages:1-5 ; date:12.2020
Scientific reports ; 10, Heft 1 (29.10.2020), 1-5, 12.2020
- Creator
-
Tashiro, Yoshihiko
Nishino, Hiroto
Higuchi, Takashi
Sugisawa, Norihiko
Fukuda, Yasunari
Yamamoto, Jun
Inubushi, Sachiko
Aoki, Takeshi
Murakami, Masahiko
Singh, Shree Ram
Bouvet, Michael
Hoffman, Robert M.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-020-75210-6
- URN
-
urn:nbn:de:101:1-2020120720562138815319
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tashiro, Yoshihiko
- Nishino, Hiroto
- Higuchi, Takashi
- Sugisawa, Norihiko
- Fukuda, Yasunari
- Yamamoto, Jun
- Inubushi, Sachiko
- Aoki, Takeshi
- Murakami, Masahiko
- Singh, Shree Ram
- Bouvet, Michael
- Hoffman, Robert M.
- SpringerLink (Online service)
Other Objects (12)
The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys
Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone
The PPARγ agonist pioglitazone prevents TGF-β induced renal fibrosis by repressing EGR-1 and STAT3
Post-treatment with the PPAR-γ agonist pioglitazone inhibits inflammation and bacterial growth during Klebsiella pneumonia
PIAS1 protects against myocardial ischemia-reperfusion injury by stimulating PPARγ SUMOylation
A translocator protein 18 kDa agonist protects against cerebral ischemia/reperfusion injury
![Synthese und pharmakologische Testung potentieller PPARγ-Agonisten [PPARgamma-Agonisten] ausgehend von Telmisartan](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Synthese und pharmakologische Testung potentieller PPARγ-Agonisten [PPARgamma-Agonisten] ausgehend von Telmisartan
Treatment with the PPARγ Agonist Pioglitazone in the Early Post-ischemia Phase Inhibits Pro-inflammatory Responses and Promotes Neurogenesis Via the Activation of Innate- and Bone Marrow-Derived Stem Cells in Rats
Effekte von PPARγ-Agonisten [PPAR-Gamma-Agonisten] auf Proliferation und Differenzierung humaner Nebennierenrindenkarzinomzellen
Anwendung des PPARγ-Agonisten [PPAR-Gamma-Agonisten] Pioglitazon bei Patienten mit aktiver Psoriasisarthritis
Untersuchung erkrankungsmodifizierender und antiepileptogener Effekte eines PPARγ-Agonisten [PPAR-gamma-Agonisten] in chronischen Epilepsiemodellen
Regulation of renal ischemia-reperfusion injury and tubular epithelial cell ferroptosis by pparγ m6a methylation: mechanisms and therapeutic implications
The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys
Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone
The PPARγ agonist pioglitazone prevents TGF-β induced renal fibrosis by repressing EGR-1 and STAT3
Post-treatment with the PPAR-γ agonist pioglitazone inhibits inflammation and bacterial growth during Klebsiella pneumonia
PIAS1 protects against myocardial ischemia-reperfusion injury by stimulating PPARγ SUMOylation
A translocator protein 18 kDa agonist protects against cerebral ischemia/reperfusion injury
Synthese und pharmakologische Testung potentieller PPARγ-Agonisten [PPARgamma-Agonisten] ausgehend von Telmisartan
Treatment with the PPARγ Agonist Pioglitazone in the Early Post-ischemia Phase Inhibits Pro-inflammatory Responses and Promotes Neurogenesis Via the Activation of Innate- and Bone Marrow-Derived Stem Cells in Rats
Effekte von PPARγ-Agonisten [PPAR-Gamma-Agonisten] auf Proliferation und Differenzierung humaner Nebennierenrindenkarzinomzellen
Anwendung des PPARγ-Agonisten [PPAR-Gamma-Agonisten] Pioglitazon bei Patienten mit aktiver Psoriasisarthritis
Untersuchung erkrankungsmodifizierender und antiepileptogener Effekte eines PPARγ-Agonisten [PPAR-gamma-Agonisten] in chronischen Epilepsiemodellen
Regulation of renal ischemia-reperfusion injury and tubular epithelial cell ferroptosis by pparγ m6a methylation: mechanisms and therapeutic implications
The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys
Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone
The PPARγ agonist pioglitazone prevents TGF-β induced renal fibrosis by repressing EGR-1 and STAT3
Post-treatment with the PPAR-γ agonist pioglitazone inhibits inflammation and bacterial growth during Klebsiella pneumonia
PIAS1 protects against myocardial ischemia-reperfusion injury by stimulating PPARγ SUMOylation
A translocator protein 18 kDa agonist protects against cerebral ischemia/reperfusion injury
Synthese und pharmakologische Testung potentieller PPARγ-Agonisten [PPARgamma-Agonisten] ausgehend von Telmisartan
Treatment with the PPARγ Agonist Pioglitazone in the Early Post-ischemia Phase Inhibits Pro-inflammatory Responses and Promotes Neurogenesis Via the Activation of Innate- and Bone Marrow-Derived Stem Cells in Rats
Effekte von PPARγ-Agonisten [PPAR-Gamma-Agonisten] auf Proliferation und Differenzierung humaner Nebennierenrindenkarzinomzellen
Anwendung des PPARγ-Agonisten [PPAR-Gamma-Agonisten] Pioglitazon bei Patienten mit aktiver Psoriasisarthritis
Untersuchung erkrankungsmodifizierender und antiepileptogener Effekte eines PPARγ-Agonisten [PPAR-gamma-Agonisten] in chronischen Epilepsiemodellen